Dofequidar

DB14067InvestigationalSmall molecule

Dofequidar is an antineoplastic agent.

Chemical structure of Dofequidar
Formula / weight
C30H31N3O3 · 481.596 g/mol (avg)

Resolves to

Compound
UNII0BJK6B565BCAS129716-58-1ChEMBLCHEMBL65067
Structure
InChIKeyKLWUUPVJTLHYIM-UHFFFAOYSA-NSMILESOC(COC1=CC=CC2=C1C=CC=N2)CN1CCN(CC1)C(=O)C(C1=CC=CC=C1)C1=CC=CC=C1
Targets
P21439ABCB4Q2M3G0ABCB5P08183ABCB1
Transporters
P08183ABCB1

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
7+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dofequidar, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In